David Johnson
Chairman chez ZENTALIS PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
David M.
Johnson was the founder of VelosBio, Inc. (founded in 2017) where he served as the Chief Executive Officer & Director from 2017 to 2020.
He is also the founder of Solve Therapeutics, Inc. Mr. Johnson's current jobs include being the Chairman of Presage Biosciences, Inc. since 2016, the Non-Executive Chairman of Aura Biosciences, Inc. since 2021, the Chairman of Zentalis Pharmaceuticals, Inc. since 2020, the Chairman of Lengo Therapeutics, Inc. since 2021, and an Independent Director of Palleon Pharmaceuticals, Inc. since 2021.
His former jobs include being the Chief Executive Officer of Acerta Pharma BV from 2013 to 2016 and serving as Chairman of Oncternal Oncology, Inc. He also held a director position at AgFeed Industries, Inc. in 2011.
Mr. Johnson's education includes an undergraduate degree from Indiana University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC
0,86% | 08/11/2023 | 425 339 ( 0,86% ) | 3 M $ | 31/03/2024 |
| 10/11/2023 | 144 389 ( 0,20% ) | 2 M $ | 31/03/2024 |
Postes actifs de David Johnson
| Sociétés | Poste | Début |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Chairman | 16/05/2022 |
| AURA BIOSCIENCES, INC. | Chairman | 01/01/2021 |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Chairman | - |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Chairman | 11/05/2021 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Director/Board Member | 02/11/2021 |
Solve Therapeutics, Inc.
 Solve Therapeutics, Inc. BiotechnologyHealth Technology Solve Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops novel antibody-based therapies targeting tumor-specific antigens. The company is based in Belmont, CA, and has subsidiaries in the United States. The company's formation has reunited members of the former VelosBio Inc. team, a highly experienced group with a proven ability to rapidly advance innovative therapeutics that address unmet medical needs in the treatment of cancer. Solvetx has been actively pursuing discovery and development efforts at its state-of-the-art laboratory facilities. The company has licensed or generated targeting antibodies and nanobodies with ideal characteristics to serve as the backbones for antibody-based therapeutics and has rights to technology supporting the development of diagnostic and therapeutic antibody-radionuclide conjugates (ARCs). Solvetx is supported by a syndicate of sophisticated healthcare investors, including Ayurmaya Capital Management Fund (an affiliate of Matrix Capital Management), Decheng Capital, General, and Surveyor Capital (a Citadel company). The company was founded by David M. Johnson and has been led by him as the CEO since incorporation. | Founder | - |
Anciens postes connus de David Johnson
| Sociétés | Poste | Fin |
|---|---|---|
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | Founder | 01/12/2020 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Chief Executive Officer | 01/03/2016 |
| AGFEED INDUSTRIES, INC. | Director/Board Member | 15/09/2011 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Formation de David Johnson
| Indiana University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AURA BIOSCIENCES, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
AgFeed Industries, Inc.
 AgFeed Industries, Inc. Agricultural Commodities/MillingProcess Industries Agfeed Industries, Inc. engages in the manufacture and sale of hogs and hog feeds. Its operating business focuses in hog production and animal nutrition. It is also involved in the processing of meat. The company was founded by Feng Zhou, Junhong Xiong, Songyan Li & Zhengru Xiong on May 1, 1995 and is headquartered in Nanning City, China. | Process Industries |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Commercial Services |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | Commercial Services |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Health Technology |
Solve Therapeutics, Inc.
Solve Therapeutics, Inc. BiotechnologyHealth Technology Solve Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops novel antibody-based therapies targeting tumor-specific antigens. The company is based in Belmont, CA, and has subsidiaries in the United States. The company's formation has reunited members of the former VelosBio Inc. team, a highly experienced group with a proven ability to rapidly advance innovative therapeutics that address unmet medical needs in the treatment of cancer. Solvetx has been actively pursuing discovery and development efforts at its state-of-the-art laboratory facilities. The company has licensed or generated targeting antibodies and nanobodies with ideal characteristics to serve as the backbones for antibody-based therapeutics and has rights to technology supporting the development of diagnostic and therapeutic antibody-radionuclide conjugates (ARCs). Solvetx is supported by a syndicate of sophisticated healthcare investors, including Ayurmaya Capital Management Fund (an affiliate of Matrix Capital Management), Decheng Capital, General, and Surveyor Capital (a Citadel company). The company was founded by David M. Johnson and has been led by him as the CEO since incorporation. | Health Technology |
